COALITION FOR ACCESS NOW

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

—

Filings

Firms Hired

Active Period

2022–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	3	1
2025	—	4	1
2024	—	4	1
2023	—	4	1
2022	—	3	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
BOSE PUBLIC AFFAIRS GROUP	—	18

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	17
SENATE	17
Food & Drug Administration (FDA)	2
Health & Human Services, Dept of (HHS)	2
White House Office	2

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	18

Bills Explicitly Cited (10)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 1629118th Congress

Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023

2024 · fourth_quarter · Firm: BOSE PUBLIC AFFAIRS GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $45,000

Matched citations: H.R.1629

H.R. 1629118th Congress

Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023

2024 · third_quarter · Firm: BOSE PUBLIC AFFAIRS GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $45,000

Matched citations: H.R.1629

H.R. 1629118th Congress

Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023

2024 · second_quarter · Firm: BOSE PUBLIC AFFAIRS GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $45,000

Matched citations: H.R.1629

H.R. 1629118th Congress

Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023

2024 · first_quarter · Firm: BOSE PUBLIC AFFAIRS GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $45,000

Matched citations: H.R.1629

Show 6 more cited filings

H.R. 1629118th Congress

Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023

2023 · fourth_quarter · Firm: BOSE PUBLIC AFFAIRS GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $45,000

Matched citations: H.R.1629

H.R. 1629118th Congress

Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023

2023 · third_quarter · Firm: BOSE PUBLIC AFFAIRS GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $45,000

Matched citations: H.R.1629

H.R. 1629118th Congress

Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023

2023 · second_quarter · Firm: BOSE PUBLIC AFFAIRS GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $45,000

Matched citations: H.R.1629

H.R. 1629118th Congress

Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023

2023 · first_quarter · Firm: BOSE PUBLIC AFFAIRS GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $45,000

Matched citations: H.R.1629

H.R. 841117th Congress

Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021

2022 · fourth_quarter · Firm: BOSE PUBLIC AFFAIRS GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $45,000

Matched citations: H.R.841

H.R. 841117th Congress

Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021

2022 · third_quarter · Firm: BOSE PUBLIC AFFAIRS GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $45,000

Matched citations: H.R.841

Source: Senate LDA

COALITION FOR ACCESS NOW — Lobbying Disclosure | Poliscope